| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6165 |
| Human Intestinal Absorption | HIA+ | 0.9756 |
| Caco-2 Permeability | Caco2+ | 0.8867 |
| P-glycoprotein Substrate | Non-substrate | 0.7340 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9815 |
| Non-inhibitor | 0.9937 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9167 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8764 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7962 |
| CYP450 2D6 Substrate | Non-substrate | 0.9233 |
| CYP450 3A4 Substrate | Non-substrate | 0.7660 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9517 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7984 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9659 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7644 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8675 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8525 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9631 |
| Non-inhibitor | 0.9734 |
| AMES Toxicity | Non AMES toxic | 0.9829 |
| Carcinogens | Non-carcinogens | 0.8627 |
| Fish Toxicity | High FHMT | 0.7460 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7307 |
| Honey Bee Toxicity | High HBT | 0.7317 |
| Biodegradation | Ready biodegradable | 0.8086 |
| Acute Oral Toxicity | III | 0.7939 |
| Carcinogenicity (Three-class) | Non-required | 0.7871 |